Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

The word “arthritis” describes pain, stiffness, and swelling in the joints. It can be a bit of a nuisance or extremely ...

Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...

Have you been diagnosed with Rheumatoid Arthritis? Try to add these 5 medicinal leaves to your daily diet routine to get ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

Rheumatoid arthritis (RA) is associated with a higher rate of ... muscle and bone diseases. Various treatments are available. Non-pharmacological treatment includes physical therapy, orthoses ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.

Anemia is prevalent among patients with rheumatoid arthritis (RA), according to a study published online Oct. 26 in Cureus.